Cargando…

Mitigating the Emerging Threat of Mucormycosis in COVID-19

Detalles Bibliográficos
Autor principal:	Pothiawala, Sohil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198662/ http://dx.doi.org/10.1177/20101058211034951

Ejemplares similares

COVID-19 and its danger of distraction
por: Pothiawala, Sohil
Publicado: (2020)

Mucormycosis—A serious threat in the COVID-19 pandemic?
por: Szarpak, Lukasz, et al.
Publicado: (2021)

Airway Management in the Emergency Department During Coronavirus Disease (COVID-19)
por: Pothiawala, Sohil
Publicado: (2020)

COVID-19 associated mucormycosis – An emerging threat
por: Chao, Chien-Ming, et al.
Publicado: (2022)

Bell’s Palsy After Second Dose of Moderna COVID-19 Vaccine: Coincidence or Causation?
por: Pothiawala, Sohil
Publicado: (2021)

Rhinocerebral Mucormycosis: An Emerging Threat in the Era of COVID-19
por: Maassarani, Deoda, et al.
Publicado: (2022)

COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021)

Mucormycosis in COVID-19: The Indian scenario
por: Ghosh, Ritwik, et al.
Publicado: (2022)

Prevention of mucormycosis in COVID-19 – the need of the hour
por: Ish, Pranav, et al.
Publicado: (2021)

Triple challenge of diabetes, COVID-19, and mucormycosis
por: Rastogi, Ashu, et al.
Publicado: (2021)

Mucormycosis Following COVID-19 Infections: an Insight
por: Das, Srijit, et al.
Publicado: (2021)

Mucormycosis: A killer in the shadow of COVID-19
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

COVID-19 and Rhino-Cerebral Mucormycosis: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Singh, Awadhesh K, et al.
Publicado: (2021)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

COVID-19 associated mucormycosis - a recent challenge
por: dos Santos, Vitorino Modesto, et al.
Publicado: (2023)

The surge in Covid related mucormycosis
por: Chandra, Somesh, et al.
Publicado: (2021)

A toddler infected with mucormycosis – reporting the youngest case of mucormycosis in post COVID phase
por: Kubre, Jyotsna, et al.
Publicado: (2023)

Digital eye strain in the era of COVID-19 pandemic: An emerging public health threat
por: Bhattacharya, Sudip, et al.
Publicado: (2020)

Emergence of co-infection of COVID-19 and dengue: A serious public health threat
por: Saddique, Arbab, et al.
Publicado: (2020)

“Mask Mouth Syndrome”-An emerging oral health threat during the COVID-19 pandemic
por: Bhattacharya, Sudip
Publicado: (2022)

COVID-19, steroids, and mucormycosis: What an ophthalmologist should know
por: Tandon, Abhishek, et al.
Publicado: (2021)

Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Ravani, Swati A, et al.
Publicado: (2021)

Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?
por: Nath, Sayan, et al.
Publicado: (2021)

COVID 19 infection and mucormycosis—a dangerously increasing combination
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla
por: Ingle, Yashwant, et al.
Publicado: (2022)

COVID-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg
por: Parsaei, Amirhossein, et al.
Publicado: (2022)

Rhino-Orbito-Cerebral Mucormycosis (ROCM) in COVID-19 Patients
por: Sharma, Vagisha, et al.
Publicado: (2023)

Spontaneous subarachnoid hemorrhage as a differential diagnosis of pre-hospital cardiac arrest
por: Pothiawala, Sohil
Publicado: (2012)

Food and Shelter Standards in Humanitarian Action
por: POTHIAWALA, Sohil
Publicado: (2016)

A modified stroke code for acute ischemic strokes during the coronavirus disease-2019 pandemic
por: Pothiawala, Sohil
Publicado: (2020)

A case report of ivory vertebra sign: an initial radiological manifestation of underlying abdominal malignancy
por: Pothiawala, Sohil
Publicado: (2022)

Additional insights on COVID-associated mucormycosis
por: Panta, Prashanth
Publicado: (2022)

COVID-19: Is Reinfection a Threat or Not?
por: PORRAS VILLAMIL, Julián Felipe, et al.
Publicado: (2020)

Preliminary Planning for Mucormycosis in Developing Countries During COVID-19 Pandemic
por: Shakrawal, Neha, et al.
Publicado: (2021)

COVID-19 associated mucormycosis (CAM): A tale of two pathogens
por: Pustake, Manas, et al.
Publicado: (2021)

Comment to: “Association of COVID-19 with Rhino-Cerebral Mucormycosis: An Observational Study”
por: Vaidyanathan, Aiswarya, et al.
Publicado: (2022)

Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023)

Candida Blankii Candidemia an Emerging Threat
por: Ahmadkhani, Fardin, et al.
Publicado: (2023)

Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine
por: Saudagar, Vrushali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g3clejs7ov7uloovkt8ecdg8fp